The major complement-fixing antigen of Mycoplasma pneumoniae is found in the lipid fraction of the organism. When the lipids of M. pneumoniae were fractionated by column chromatography on silicic acid, serological activity against both rabbit and human immune sera was found in two fractions, B (12) . The dialysate medium was supplemented with 12% "agamma" horse serum. Antibacterials were penicillin (200 units/ml) and thallium acetate (0.5 mg/ml).
The serological activity of Mycoplasma pneumoniae, as measured by complement fixation against both human and rabbit immune sera, is found primarily in the lipid fraction (13) . M. pneumoniae is a major cause of atypical pneumonia and nearly all patients infected with this human pathogen show an antibody response measurable by complement fixation with lipid preparations (6, 7) .
Lipids can easily be separated from other cellular components, proteins, and polysaccharides. This factor and the relative chemical stability of lipids present advantages for characterization of serologically active components, particularly from a group of organisms such as the Mycoplasmataceae, which can be cultivated only at considerable expense with very small yields. Current knowledge indicates that lipid antigens are rare in nature, and an organism in which the major antigenic determinant is lipid would be unique and commend itself to study (24) . [Antigen, as used in this paper, refers to a serologically active component without necessarily implying immunogenicity or any particular size of the reactive complex, since the serologically reactive lipid is 1 Some of the data in this paper were presented in a preliminary communication, Bacteriol. Proc. p. 94, 1967. probably not the single molecule but is in the form of a micelle of relatively large molecular weight (8, 26) .] The partial characterization of two distinct serologically active fractions recovered from M. pneumoniae is presented in this report.
MATERIALS AND METHODS Cultivation of M. pneumoniae. M. pneumoniae strain AP-164 (13) , M. fermentans PG-18, and M. laidlawii strain B were cultivated in a dialysate medium derived from dried active yeast and soy peptone (12) . The dialysate medium was supplemented with 12% "agamma" horse serum. Antibacterials were penicillin (200 units/ml) and thallium acetate (0.5 mg/ml).
The strain of M. pneumoniae used in these experiments was employed between the 9th and 12th transfers on artificial medium from the patient. The 800-ml cultures were agitated with magnetic spin bars and were incubated 4 to 5 days at 37 C (2 to 3 days for M. laidlawii at 32 C). The culture medium was acidic at this point. The organisms were concentrated from the medium by centrifugation at 10,000 X g. The pellet was washed three times with phosphatebuffered saline. The organisms were suspended in water and were lyophilized. Each liter of culture yielded approximately 20 mg (dry weight) of orga- nisms.
Extraction and fractionation of lipids. The total lipid, comprising 14 to 18% (dry weight) of the organisms, was extracted from 200 to 300 mg of lyophi-BECKMAN AND KENNY lized mycoplasmata by suspending the dried organisms in 200 ml of chloroform and 100 ml of methanol overnight at 4 C. The extract was washed with 75 ml of 0.1 M KCI (5). Chloroform-methanol (2:1) was used because it was more effective than neutral solvents for complete extraction of the serologically reactive components from M. pneumoniae (13) . The organic solvent was evaporated in vacuo with a rotary evaporator and the lipid residue was reconstituted in 5 ml of chloroform.
This lipid extract, containing 400 to 700 ,ug of lipid phosphorus, was applied to a silicic acid chromatographic column composed of 2 g of activated silicic acid (100 mesh; Mallinckrodt, St. Louis, Mo.) and 1 g of Hyflo-supercel. The resulting column (1 X 9 cm) had a void space of 3 ml. Neutral lipids, choleaterol-esters, triglycerides and diglycerides, free fatty acids, and cholesterol were eluted with 50 ml of chloroform (0.5 ml/min). Polar lipids or phospholipids were then eluted sequentially with solvents of increasing polarity. Fraction A was eluted with choloroform-methanol (20:1), fraction B with choloroform-methanol (9:1), fraction C with chloroform-methanol (6:1), fraction D with ethyl acetatemethanol (3.5:2), fraction E with chloroformmethanol (1:1), and fraction F with chloroformmethanol (1: 20) . The elution volume for each solvent (fraction) was 30 ml, collected in 5-ml subfractions. Two 1-ml samples were removed from each tube for duplicate nitrogen analysis and 0.5 ml was analyzed for total phosphorus. The contents remaining in each tube were dried under a stream of nitrogen and suspended in 1 ml of absolute ethyl alcohol for assay of serological activity by complement fixation.
The lipids eluted in each fraction were examined by thin-layer chromatography on Silica Gel G (E. Merck AG, Darmstadt, Germany). Sugar-containing phospholipids were separated by thin-layer chromatography on Silica Gel H impregnated with sodium tetraborate. The plates were prepared by the method of Hakomori and Strycharz (9) . Samples were applied in 20 (33) . Glycerol analysis was by the method of Hanahan and Olley (10) in which the formaldehyde produced by oxidation of glycerol with periodate is reacted with chromotropic acid in a strong sulfuric acid solution. The periodate oxidation was carried out directly on the 1 N HCl hydrolysates as in the modified procedure of Wells and Dittmer (34) .
Lipid samples were analyzed for carbohydrate content after hydrolysis with 4 N HCl at 100 C for 3 hr in screw-capped tubes. The HCl was evaporated with a jet of air and the residue was dissolved in water. Hydrolysates were applied to Whatman no. 1 paper and chromatographed for 18 hr by descending technique, with ethyl acetate-pyridine-water (12:5:4) as the solvent (11) . Carbohydrates on the chromatograms were detected with alkaline silver nitrate reagent (32).
Infrared absorption spectra were obtained with a Beckman IR4 double-beam spectrophotometer. Samples were examined as liquid films on pressed sintered zinc sulfide (Itran 2, Connecticut Instrument Co., Wilton, Conn.) A scale expansion apparatus was employed.
Antisera. Antisera were prepared by immunizing rabbits with M. pneumoniae strain AP-164, M. laidlawii strain B, and M. fermentans PG-18 cultivated in dialysate broth supplemented with agamma calf serum. Specific details of the immunization procedure are described elsewhere (12) . Human M. pneumoniae antisera were obtained trom convalescent pneumonia patients from whom M. pneumoniae had been isolated (6) .
Complement-fixation technique. The complementfixation test employed was a modification of the Kolmer technique (18) scaled for use with microtitration equipment (27) . Antigen and antibody titers were determined by block titration of twofold dilutions of antigen against twofold dilutions of antiserum. Two full units of complement were employed. Fixation of complement to the antigen-antibody complex was facilitated by incubation at 4 C for 18 hr prior to the addition of sensitized erythrocytes. End points were designated as that initial dilution containg the least amount of antigen or antibody which completely prevented hemolysis of the sensitized sheep red blood cells. Crude lipid extracts and subfractions eluted from the silicic acid column were titrated as ethyl alcohol suspensions against rabbit and human antisera. The ethyl alcohol suspension was serially diluted in complement-fixing diluent.
Ethyl alcohol did not give false-positive or negative reactions even at a dilution of 1:6 (i.e., the first dilution).
RESULTS
Extraction of M. pneumoniae lipids. Chloroform-methanol extraction of the lipids of M. pneumoniae completely partitions the serologically active components of the organism into the solvent phase, with no complement-fixing activity remaining in either the residue or the 0.1 M KC1 when tested against human sera. Overnight extraction with chloroform-methanol in the cold did not appear to result in an increased formation of degradation products when compared with less prolonged exposure of the lyophilized organisms to the solvent; no additional products were observed on thin-layer chromatograms, and complement-fixation titers were unchanged. However, the possibility that degradation products are represented in the lipids extracted cannot be ruled out, because the broth cultures were acidic during the last 24 to 48 hr of growth.
Fractionation of M. pneumoniae lipids. The lipids of M. pneumoniae were fractionated by silicic acid column chromatography. The major phospholipids were found in fractions D, E, and F; fractions B and C contained minor phospholipid components ( Fig. 1 and 2 ). When these fractions were examined by thin-layer chromatography on Silica Gel G plates, A and B were found to contain several unidentified lipids. Fraction C contained a very minor component which migrated with phosphatidylethanolamine as well as a component chromatographically identical to fraction D. Fraction D appeared as a single "comet-shaped" spot on plates charred with sulfuric acid. Fractions E and F contained two lipids which migrated with phosphatidylcholine and sphingomyelin.
Serological activity. Significant complementfixing activity against human antisera was found in fractions B, C, and D. Complement-fixing activity was found to coincide with peak phosphate levels in subfractions of fraction D (Fig. 1 ). This coincidence was not so clear for fraction B. The complement-fixing activity found in fraction C was found to be the result of overloading the column with respect to fraction D. This was evident both on rechromatography on silicic acid and thin-layer chromatography on Silica Gel G.
The relative complement-fixing activity of the fractions was compared on a molar basis by calculating the titer of a solution containing 1 ,umole of phosphorus per ml (CF/P ratio). The CF/P ratio for fraction B was 400; the CF/P ratio for fraction D was 1,000. (This difference was found in several experiments but may not be significant because of the twofold dilution scheme used for complement-fixing assay.) Fraction D was further characterized, but fraction B was not because considerably smaller amounts of lipid were available for analysis. The relative complement-fixing antigen titers of fraction D and crude lipid extract were approximately equal; hence, complementfixing activity was not lost as a result of the fractionation process. Furthermore, the CF/P ratio did not change when the silicic acid column was eluted with acetone prior to the polar solvents, thus lessening the possibility that neutral glycolipids (not containing phosphorus) contributed to the serological activity of fractions B and D. Serological specificity. Since mycoplasmata are usually cultivated in media containing protein supplements, contamination of the concentrated organisms with extraneous antigens is quite likely. The lipid composition of the Mycoplasmataceae frequently mimics to some degree the lipid composition of the medium (28) . To establish that the complement-fixing activity was derived from the organism, the lipid component of agamma horse serum (extracted from 4 g of lyophilized serum, as described for M. pneumoniae) was compared with M. pneumoniae lipids by thin-layer chromatography (Fig. 3) Lipids extracted from lyophilized agamma horse serum and from dialysate broth showed only minimal complement-fixing antigen titers against human antisera (1:4). These lipids were employed in concentrations equivalent to the mycoplasmal lipids. (If the mycoplasmata had adsorbed all the serologically active lipids in the medium, the resulting complement-fixing titer from medium lipids would have been 1:4, whereas the M. pneumoniae lipid titer was 1:128.) The serological activity of both M. fermentans and M. pneumoniae lipids could be distinguished from medium lipids in a previous study (12) . (Fig. 2) , shows that fraction D contained phosphorous but not nitrogen. The infrared spectrum of a liquid film of fraction DPN (Fig. 6) showed predominant a Titer is given as the reciprocal of the highest initial antigen (or antibody) dilution giving complete fixation of complement in a block titration. absorption in the 3-,m region characteristic of hydroxyl groups, carbon-hydrogen bonding at 3.5 ,um, ester linkage at 5.8 ,um, and phosphate ester and ethers in the region of 9 to 9.5 jsm. This spectrum suggests the presence of carbohydrate residues and confirms that fraction DPN does not contain nitrogen, since significant absorption was observed neither in the 6.0 to 6.8 region characteristic of the NH group nor at 8.25 ,um characteristic of secondary amides.
Fraction DPN was then hydrolyzed and analyzed for carbohydrate content by paper chromatography. Two sugars were detected which migrated with glucose and galactose (standards obtained as NRC grade from General Biochemicals, Chagrin Falls, Ohio), respectively. Glycerol analysis of fraction DPN hydrolysates indicated that glycerol and phosphorus were present in equimolar amounts, 0.25 .Mm glycerol to 0.22 ,uM phosphorus.
The preceding analyses were based on the assumption that fraction DPN was homogeneous. (Fig. 7) which migrated between phos- (12) .
b Antisera from rabbits immunized with washed organisms cultivated in dialysate broth supplemented with agamma calf serum.
¢ Titer is given as the reciprocal of the highest initial antigen (or antibody) dilution giving complete fixation of complement in a block titration.
d Samples taken from first 5-ml fraction of D.
phatidylethanolamine (RF = 0.52) and phosphatidylcholine (RF = 0.24). Similar cometshaped spots were observed in the D fractions of M. fermentans and M. laidlawii on Silica Gel G. However, when the comet-shaped spot of fraction DPN was sprayed with orcinol sulfuric acid reagent, it was found to be heterogeneous (Fig.  8) . It appeared possible to further resolve the sugar-containing components by Hakomori and Strycharz's method of thin-layer chromatography on borate-impregnated Silica Gel H (9), where carbohydrate-containing lipids are retarded proportionately to sugar residue content. Fractions DF, DLB, and DPN were compared by this method (Fig. 9 ). Fractions DF and DLB both separated into two components, one of which gave a positive hexose reaction when sprayed with the orcinol-sulfuric acid reagent and migrated with phosphatidylglucose. M. pneumoniae fraction DpN contained only a minor component which migrated with phosphatidylglucose but showed three larger spots, presumably containing di-, tri-, and tetrahexoses, because they were retarded proportionately. The least polar component, common to all three fractions, gave a negative reaction with the orcinol-sulfuric acid reagent.
DIscussIoN
The results presented in this paper lead to the conclusion that the complement-fixing antigen in the most reactive lipid fraction of M. pneumoniae (4) (9) .
Additional evidence in support of the role conceivably played by sugar residues in determining the serological specificity of lipid extracts of M. pneumoniae was provided by Lemcke et al. (17) . Silica Gel G as it appears when charred with sulfuric acids (Fig. 7) by first exposing the thin-layer chromatographic plate to iodine vapors to locate the comet and then spraying with 0.25% orcinol in 2 N sulfuric acid, which stains the three hexose-containing spots.
They have reported that the complement-fixing activity of a chloroform-methanol extract was reduced by treatment with periodate and also by mixed carbohydrases. They consequently suggested that the active component could be glycolipid. We can confirm this in that we found the serological activity in fraction DPN periodate labile. Also interesting in this regard is their demonstration of a serological cross-reaction between a lipid extract from M. pneumoniae and a galactan preparation from M. mycoides (19 pneumoniae infections in a pneumonia incidence study of a civilian population (6, 7) . Nearly all patients, over a 5-year period, from whom M. pneumoniae had been isolated, showed antibody increase or high titers in paired sera to this test antigen. Since the AP-164 strain was isolated in 1963, it appears that substantial strain variation with regard to the major lipid antigen had not occurred in Seattle by 1967. Strain AP-164 was deliberately chosen because it was a wild strain (isolated from an ill patient) which had been transferred a minimal number of times on artificial medium and hence had less opportunity for alteration from the virulent state.
A lipid antigen for M. mycoides has been reported (3) which accounted for the majority of the complement-fixing activity of M. mycoides but did not cross-react with lipid preparations of M. pneumoniae (19) . The nature of the serologically active lipid of M. mycoides is unknown; Plackett (21) reported that the main glycolipid synthesized by M. mycoides was a neutral lipid which contained fatty acid esters, glycerol, and galactose in the ratio of 2:1:1. Glycerolphosphorylglycerol and glycerolphosphorylglycerolphosphorylglycerol deacylation products of phospholipids were also recovered. The serological activity of these fractions was not reported. A limited survey of six other Mycoplasma species (12) showed that only M. fermentans possessed a serologically active lipid component as the major complement-fixing antigen. Hence (25) and globoside (ceramide-glucose-galactose-N-acetylgalactosamine) (35) . Glycosyldiglycerides from a number of the gram-positive bacteria were described by Brundish et al. (2) . The glycolipids of acid-fast bacteria have been reviewed by Lederer (15) .
The study of the immunological characteristics of lipids is still a relatively new field of research.
Immunochemical and serological methods have been difficult to apply to lipid systems for at least two reasons: (i) the limited solubility of lipids in aqueous medium, and (ii) a lack of insight con-cerning the physical and chemical nature of lipidlipid interactions, owing to their amphipathic character in aqueous systems.
To date, complement-fixation has been the method giving the most consistent results in assaying serologically active lipids. Complement-fixing antigen titers of lipids are frequently greatly increased when a mixture of lecithin and cholesterol (equal parts by weight) is added to the purified lipid at ratios of up to 100:1, as reported by Rapport and Rapport et al. (24, 25) in studies with cytolipin H and by Pangborn (20) with cardiolipin. Lecithin and cholesterol react with the lipid antigen to form stable micelles which, behaving as macromolecules (8) , are then capable of reacting with homologous antibody to fix complement. Consequently, serological activity may diminish as purification proceeds because of the separation of auxiliary lipids from the active component (24) .
Fraction DPN did not appear to require auxiliary lipids for serological activity: (i) the complement-fixing antigen titer of fraction DPN was approximately equal to that of the starting crude lipid extract, and (ii) the titer was not increased on attempts to complex it to bovine albumin. Therefore, it appears that the serological activity of fraction DPN depends, in part, on its ability to form micelles in the absence of additional lipids.
